Φακοί επαφής που επιδιορθώνονται με ακτινοβολία UV

Dear Friends, and dear Colleagues,On behalf of the the European Pancreatic Club/ EPC it is a great honor for me to welcome you to the wonderful and breathtaking city of Istanbul for the joint EPC/IAP Meeting 2026. In Istanbul not only Europe gets united with Asia but Istanbul also welcomes the entire World. For that reason it is just the perfect city to held a joint meeting with the International Association of Pancreatology/IAP to unify Europe and the rest of the World for our beloved pancreas. It is not only important to meet all together, but also to built a platform where we all can collaborate and actively work in a joint manner for our patients with pancreatic diseases. In this dimension, it is not only important to unify the knowledge of pancreatologists from all over the world but also to do this in a multidisciplinary fashion.In these times, there is no single pancreatic disease, which can be perfectly treated by one medical discipline only. It is the specialised team which matters and gives our patients the best therapy they need. Neither a single good gastroenterologist, an oncologist, an interventional radiologist, a radiation oncologist or a surgeon can stand alone in the complex modern treatment tracks we have established for pancreatic diseases nowadays. In this context, we should also not forget the importance of our specialized nurses who are taking care for our patients. Therefore our joint meeting 2026 will highlight and once more underline why multidisciplinary approach is the only key to success in pancreatology.Pancreatology can only develop through joint academic research, multinational networking, successful publishing and establishing of evidence based medicine guidelines and therapy strategies. In this matter we also need strongly our colleagues from basic science who help us to develop and understand the pathogenesis of the diseases we are dealing with. We should not forget that basic science is crucial to master the pathophysiology, the course and also novel therapeutic approaches in pancreatic diseases. For that reasons basic science will play a major role at the EPC/IAP joint meeting in Istanbul 2026.For that reason my friends and colleagues, let us all from all over the world meet in İstanbul 2026 to gather our knowledge, academic efforts and our fight against pancreatic diseases for the benefit of our patients.See you in June 2026 in Istanbul, in the city where the world meets!!!

Learning objectivesAfter watching this webinar, participants will understand:CVD risk calculators do not accurately predict the risk of future CVD in patients with inflammatory joint diseases;that despite low lipid levels, these patients have an increased risk of CVD;lipid-lowering and anti-hypertensive treatment is uncomplicated in patients with inflammatory joint diseases and does not inflict more side effects compared with the general population; and baseline lipid levels, inflammatory status and anti-rheumatic medication do not interfere with the dose of lipid-lowering treatment needed to obtain recommended lipid levels.Needs assessment and expected educational outcomeTo update evaluation on attainment of recommended lipid and blood pressure levels in patients with inflammatory joint diseases.Main topic:Risk Factors and PreventionYou may also register for this webinar scheduled on 17 June 2026 entitled "What is cardio-rheumatology?" on the same topic.For a complete overview on cardio-rheumatology, please visit the FOCUS edition webpage. (link available soon)Session informationThis webinar is designed for general practitioners, primary care doctors and general cardiologist but also cardiologists wishing to update their scientific knowledge on the topic.During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.Technical settingsThe webinar is available on PC and tablets. The use of a smartphone is not recommended.To answer the MCQs during the live, you must allow pop-up windows.A high-speed Internet connection is required (minimum 2 Mbps).

If you wonder about your risk of developing heart rhythm issues or have a history of rhythm problems, join us to learn how often arrythmias occur in adults with congenital heart disease (CHD), symptoms to watch for, heart rhythm monitoring, and treatment options. Get your questions answered and find support on your CHD journey.